The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rechallenge with epidermal growth factor receptor inhibitors for metastatic colorectal cancer: A systematic review and meta-analysis.
 
Amy Huang
No Relationships to Disclose
 
Ronan Hsieh
No Relationships to Disclose
 
Chuan Lu
No Relationships to Disclose
 
Ibrahim Halil Sahin
Consulting or Advisory Role - GlaxoSmithKline; Guardant Health; Seagen
 
Gentry King
Consulting or Advisory Role - AstraZeneca; Ipsen
 
Rachael Safyan
Honoraria - Curio Science
Consulting or Advisory Role - Agenus; Guardant Health; Ipsen; Mirati Therapeutics
Research Funding - Exelixis (Inst); Replimune (Inst); Verastem (Inst)
 
Stacey Cohen
Consulting or Advisory Role - Abbvie; Agenus; Exact Sciences; Guardant Health; Incyte; Merck; Pfizer; Regeneron; Taiho Oncology
Research Funding - Biomea (Inst); BioNTech SE (Inst); Natera (Inst); Pfizer (Inst); Tempus (Inst)
Expert Testimony - The Cline Law Firm
Travel, Accommodations, Expenses - Biomea Fusion; Natera
 
David Zhen
Consulting or Advisory Role - Boehringer Ingelheim; Bristol Myers Squibb; Exelixis; Jazz Pharmaceuticals; Legend Biotech; Medigene
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Cornerstone Pharmaceuticals (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Legend Biotech (Inst); Lilly (Inst); Medigene (Inst); Merck (Inst); Pfizer (Inst)
 
Veena Shankaran
No Relationships to Disclose
 
William Harris
Consulting or Advisory Role - Boston Scientific; ICON Clinical Research; Merck
Research Funding - Bayer (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Koo Foundation (Inst); MedImmune (Inst); Merck (Inst); Sanofi Pasteur (Inst); zymeworks (Inst)
Expert Testimony - Boston Scientific; Merck
 
Andrew Coveler
Consulting or Advisory Role - Abbvie; Halozyme; Merrimack; Seagen
Research Funding - AbGenomics International (Inst); Actuate Therapeutics (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Newlink Genetics (Inst); Nextrast (Inst); Novocure (Inst); Nucana (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Halozyme; Nucana
 
Po-Jen Lin
No Relationships to Disclose
 
Jyoti Malhotra
Consulting or Advisory Role - Abbvie; AstraZeneca; BioAtla; Bristol Myers Squibb Foundation; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; Mirati Therapeutics; Regeneron; Sanofi; Takeda
Speakers' Bureau - Tempus
Research Funding - BeyondSpring Pharmaceuticals (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst)
 
Victoria Forbes
No Relationships to Disclose
 
E. Gabriela Chiorean
Consulting or Advisory Role - AADi; Astellas Pharma; BPGbio; Bristol-Myers Squibb/Celgene; IgM Biosciences; Ipsen; Merus; Pfizer; Purple Biotech; Regeneron; Takeda
Research Funding - Affini-T Therapeutics (Inst); BioAtla; Boehringer Ingelheim (Inst); Erasca, Inc (Inst); FibroGen (Inst); Genentech (Inst); Gilead/Forty Seven (Inst); Lonza (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merus
 
Gin Yi Lee
No Relationships to Disclose